Global Next Generation Cancer Diagnostics Market Growth (Status and Outlook) 2023-2028

Report ID: 1361652 | Published Date: Jan 2025 | No. of Page: 110 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Next Generation Cancer Diagnostics Market Size 2017-2028
        2.1.2 Next Generation Cancer Diagnostics Market Size CAGR by Region 2017 VS 2022 VS 2028
    2.2 Next Generation Cancer Diagnostics Segment by Type
        2.2.1 Next Generation Sequencing
        2.2.2 qPCR & Multiplexing
        2.2.3 DNA Microarrays
        2.2.4 Others
    2.3 Next Generation Cancer Diagnostics Market Size by Type
        2.3.1 Next Generation Cancer Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028)
        2.3.2 Global Next Generation Cancer Diagnostics Market Size Market Share by Type (2017-2022)
    2.4 Next Generation Cancer Diagnostics Segment by Application
        2.4.1 Hospitals
        2.4.2 Clinics
        2.4.3 Others
    2.5 Next Generation Cancer Diagnostics Market Size by Application
        2.5.1 Next Generation Cancer Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028)
        2.5.2 Global Next Generation Cancer Diagnostics Market Size Market Share by Application (2017-2022)
3 Next Generation Cancer Diagnostics Market Size by Player
    3.1 Next Generation Cancer Diagnostics Market Size Market Share by Players
        3.1.1 Global Next Generation Cancer Diagnostics Revenue by Players (2020-2022)
        3.1.2 Global Next Generation Cancer Diagnostics Revenue Market Share by Players (2020-2022)
    3.2 Global Next Generation Cancer Diagnostics Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion
4 Next Generation Cancer Diagnostics by Regions
    4.1 Next Generation Cancer Diagnostics Market Size by Regions (2017-2022)
    4.2 Americas Next Generation Cancer Diagnostics Market Size Growth (2017-2022)
    4.3 APAC Next Generation Cancer Diagnostics Market Size Growth (2017-2022)
    4.4 Europe Next Generation Cancer Diagnostics Market Size Growth (2017-2022)
    4.5 Middle East & Africa Next Generation Cancer Diagnostics Market Size Growth (2017-2022)
5 Americas
    5.1 Americas Next Generation Cancer Diagnostics Market Size by Country (2017-2022)
    5.2 Americas Next Generation Cancer Diagnostics Market Size by Type (2017-2022)
    5.3 Americas Next Generation Cancer Diagnostics Market Size by Application (2017-2022)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Next Generation Cancer Diagnostics Market Size by Region (2017-2022)
    6.2 APAC Next Generation Cancer Diagnostics Market Size by Type (2017-2022)
    6.3 APAC Next Generation Cancer Diagnostics Market Size by Application (2017-2022)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
7 Europe
    7.1 Europe Next Generation Cancer Diagnostics by Country (2017-2022)
    7.2 Europe Next Generation Cancer Diagnostics Market Size by Type (2017-2022)
    7.3 Europe Next Generation Cancer Diagnostics Market Size by Application (2017-2022)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Next Generation Cancer Diagnostics by Region (2017-2022)
    8.2 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Type (2017-2022)
    8.3 Middle East & Africa Next Generation Cancer Diagnostics Market Size by Application (2017-2022)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Global Next Generation Cancer Diagnostics Market Forecast
    10.1 Global Next Generation Cancer Diagnostics Forecast by Regions (2023-2028)
        10.1.1 Global Next Generation Cancer Diagnostics Forecast by Regions (2023-2028)
        10.1.2 Americas Next Generation Cancer Diagnostics Forecast
        10.1.3 APAC Next Generation Cancer Diagnostics Forecast
        10.1.4 Europe Next Generation Cancer Diagnostics Forecast
        10.1.5 Middle East & Africa Next Generation Cancer Diagnostics Forecast
    10.2 Americas Next Generation Cancer Diagnostics Forecast by Country (2023-2028)
        10.2.1 United States Next Generation Cancer Diagnostics Market Forecast
        10.2.2 Canada Next Generation Cancer Diagnostics Market Forecast
        10.2.3 Mexico Next Generation Cancer Diagnostics Market Forecast
        10.2.4 Brazil Next Generation Cancer Diagnostics Market Forecast
    10.3 APAC Next Generation Cancer Diagnostics Forecast by Region (2023-2028)
        10.3.1 China Next Generation Cancer Diagnostics Market Forecast
        10.3.2 Japan Next Generation Cancer Diagnostics Market Forecast
        10.3.3 Korea Next Generation Cancer Diagnostics Market Forecast
        10.3.4 Southeast Asia Next Generation Cancer Diagnostics Market Forecast
        10.3.5 India Next Generation Cancer Diagnostics Market Forecast
        10.3.6 Australia Next Generation Cancer Diagnostics Market Forecast
    10.4 Europe Next Generation Cancer Diagnostics Forecast by Country (2023-2028)
        10.4.1 Germany Next Generation Cancer Diagnostics Market Forecast
        10.4.2 France Next Generation Cancer Diagnostics Market Forecast
        10.4.3 UK Next Generation Cancer Diagnostics Market Forecast
        10.4.4 Italy Next Generation Cancer Diagnostics Market Forecast
        10.4.5 Russia Next Generation Cancer Diagnostics Market Forecast
    10.5 Middle East & Africa Next Generation Cancer Diagnostics Forecast by Region (2023-2028)
        10.5.1 Egypt Next Generation Cancer Diagnostics Market Forecast
        10.5.2 South Africa Next Generation Cancer Diagnostics Market Forecast
        10.5.3 Israel Next Generation Cancer Diagnostics Market Forecast
        10.5.4 Turkey Next Generation Cancer Diagnostics Market Forecast
        10.5.5 GCC Countries Next Generation Cancer Diagnostics Market Forecast
    10.6 Global Next Generation Cancer Diagnostics Forecast by Type (2023-2028)
    10.7 Global Next Generation Cancer Diagnostics Forecast by Application (2023-2028)

11 Key Players Analysis
    11.1 Cepheid
        11.1.1 Cepheid Company Information
        11.1.2 Cepheid Next Generation Cancer Diagnostics Product Offered
        11.1.3 Cepheid Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.1.4 Cepheid Main Business Overview
        11.1.5 Cepheid Latest Developments
    11.2 Koninklijke Philips N.V
        11.2.1 Koninklijke Philips N.V Company Information
        11.2.2 Koninklijke Philips N.V Next Generation Cancer Diagnostics Product Offered
        11.2.3 Koninklijke Philips N.V Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.2.4 Koninklijke Philips N.V Main Business Overview
        11.2.5 Koninklijke Philips N.V Latest Developments
    11.3 F. Hoffmann-La Roche Ltd
        11.3.1 F. Hoffmann-La Roche Ltd Company Information
        11.3.2 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product Offered
        11.3.3 F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.3.4 F. Hoffmann-La Roche Ltd Main Business Overview
        11.3.5 F. Hoffmann-La Roche Ltd Latest Developments
    11.4 Qiagen
        11.4.1 Qiagen Company Information
        11.4.2 Qiagen Next Generation Cancer Diagnostics Product Offered
        11.4.3 Qiagen Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.4.4 Qiagen Main Business Overview
        11.4.5 Qiagen Latest Developments
    11.5 Novartis AG
        11.5.1 Novartis AG Company Information
        11.5.2 Novartis AG Next Generation Cancer Diagnostics Product Offered
        11.5.3 Novartis AG Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.5.4 Novartis AG Main Business Overview
        11.5.5 Novartis AG Latest Developments
    11.6 Abbott
        11.6.1 Abbott Company Information
        11.6.2 Abbott Next Generation Cancer Diagnostics Product Offered
        11.6.3 Abbott Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.6.4 Abbott Main Business Overview
        11.6.5 Abbott Latest Developments
    11.7 Thermo Fisher Scientific
        11.7.1 Thermo Fisher Scientific Company Information
        11.7.2 Thermo Fisher Scientific Next Generation Cancer Diagnostics Product Offered
        11.7.3 Thermo Fisher Scientific Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.7.4 Thermo Fisher Scientific Main Business Overview
        11.7.5 Thermo Fisher Scientific Latest Developments
    11.8 Opko Health
        11.8.1 Opko Health Company Information
        11.8.2 Opko Health Next Generation Cancer Diagnostics Product Offered
        11.8.3 Opko Health Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.8.4 Opko Health Main Business Overview
        11.8.5 Opko Health Latest Developments
    11.9 Myriad Genetics
        11.9.1 Myriad Genetics Company Information
        11.9.2 Myriad Genetics Next Generation Cancer Diagnostics Product Offered
        11.9.3 Myriad Genetics Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.9.4 Myriad Genetics Main Business Overview
        11.9.5 Myriad Genetics Latest Developments
    11.10 Agilent Technologies
        11.10.1 Agilent Technologies Company Information
        11.10.2 Agilent Technologies Next Generation Cancer Diagnostics Product Offered
        11.10.3 Agilent Technologies Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.10.4 Agilent Technologies Main Business Overview
        11.10.5 Agilent Technologies Latest Developments
    11.11 GE Healthcare
        11.11.1 GE Healthcare Company Information
        11.11.2 GE Healthcare Next Generation Cancer Diagnostics Product Offered
        11.11.3 GE Healthcare Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.11.4 GE Healthcare Main Business Overview
        11.11.5 GE Healthcare Latest Developments
    11.12 PerkinElmer
        11.12.1 PerkinElmer Company Information
        11.12.2 PerkinElmer Next Generation Cancer Diagnostics Product Offered
        11.12.3 PerkinElmer Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.12.4 PerkinElmer Main Business Overview
        11.12.5 PerkinElmer Latest Developments
    11.13 Genomic Health
        11.13.1 Genomic Health Company Information
        11.13.2 Genomic Health Next Generation Cancer Diagnostics Product Offered
        11.13.3 Genomic Health Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.13.4 Genomic Health Main Business Overview
        11.13.5 Genomic Health Latest Developments
    11.14 Illumina
        11.14.1 Illumina Company Information
        11.14.2 Illumina Next Generation Cancer Diagnostics Product Offered
        11.14.3 Illumina Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.14.4 Illumina Main Business Overview
        11.14.5 Illumina Latest Developments
    11.15 Hologic
        11.15.1 Hologic Company Information
        11.15.2 Hologic Next Generation Cancer Diagnostics Product Offered
        11.15.3 Hologic Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.15.4 Hologic Main Business Overview
        11.15.5 Hologic Latest Developments
    11.16 Almac Group
        11.16.1 Almac Group Company Information
        11.16.2 Almac Group Next Generation Cancer Diagnostics Product Offered
        11.16.3 Almac Group Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.16.4 Almac Group Main Business Overview
        11.16.5 Almac Group Latest Developments
    11.17 Janssen Global Services
        11.17.1 Janssen Global Services Company Information
        11.17.2 Janssen Global Services Next Generation Cancer Diagnostics Product Offered
        11.17.3 Janssen Global Services Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.17.4 Janssen Global Services Main Business Overview
        11.17.5 Janssen Global Services Latest Developments
    11.18 Sysmex Corporation
        11.18.1 Sysmex Corporation Company Information
        11.18.2 Sysmex Corporation Next Generation Cancer Diagnostics Product Offered
        11.18.3 Sysmex Corporation Next Generation Cancer Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.18.4 Sysmex Corporation Main Business Overview
        11.18.5 Sysmex Corporation Latest Developments
12 Research Findings and Conclusion

List of Tables
    Table 1. Next Generation Cancer Diagnostics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
    Table 2. Major Players of Next Generation Sequencing
    Table 3. Major Players of qPCR & Multiplexing
    Table 4. Major Players of DNA Microarrays
    Table 5. Major Players of Others
    Table 6. Next Generation Cancer Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
    Table 7. Global Next Generation Cancer Diagnostics Market Size by Type (2017-2022) & ($ Millions)
    Table 8. Global Next Generation Cancer Diagnostics Market Size Market Share by Type (2017-2022)
    Table 9. Next Generation Cancer Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
    Table 10. Global Next Generation Cancer Diagnostics Market Size by Application (2017-2022) & ($ Millions)
    Table 11. Global Next Generation Cancer Diagnostics Market Size Market Share by Application (2017-2022)
    Table 12. Global Next Generation Cancer Diagnostics Revenue by Players (2020-2022) & ($ Millions)
    Table 13. Global Next Generation Cancer Diagnostics Revenue Market Share by Player (2020-2022)
    Table 14. Next Generation Cancer Diagnostics Key Players Head office and Products Offered
    Table 15. Next Generation Cancer Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 16. New Products and Potential Entrants
    Table 17. Mergers & Acquisitions, Expansion
    Table 18. Global Next Generation Cancer Diagnostics Market Size by Regions 2017-2022 & ($ Millions)
    Table 19. Global Next Generation Cancer Diagnostics Market Size Market Share by Regions (2017-2022)
    Table 20. Americas Next Generation Cancer Diagnostics Market Size by Country (2017-2022) & ($ Millions)
    Table 21. Americas Next Generation Cancer Diagnostics Market Size Market Share by Country (2017-2022)
    Table 22. Americas Next Generation Cancer Diagnostics Market Size by Type (2017-2022) & ($ Millions)
    Table 23. Americas Next Generation Cancer Diagnostics Market Size Market Share by Type (2017-2022)
    Table 24. Americas Next Generation Cancer Diagnostics Market Size by Application (2017-2022) & ($ Millions)
    Table 25. Americas Next Generation Cancer Diagnostics Market Size Market Share by Application (2017-2022)
    Table 26. APAC Next Generation Cancer Diagnostics Market Size by Region (2017-2022) & ($ Millions)
    Table 27. APAC Next Generation Cancer Diagnostics Market Size Market Share by Region (2017-2022)
    Table 28. APAC Next Generation Cancer Diagnostics Market Size by Type (2017-2022) & ($ Millions)
    Table 29. APAC Next Generation Cancer Diagnostics Market Size Market Share by Type (2017-2022)
    Table 30. APAC Next Generation Cancer Diagnostics Market Size by Application (2017-2022) & ($ Millions)
    Table 31. APAC Next Generation Cancer Diagnostics Market Size Market Share by Application (2017-2022)
    Table 32. Europe Next Generation Cancer Diagnostics Market Size by Country (2017-2022) & ($ Millions)
    Table 33. Europe Next Generation Cancer Diagnostics Market Size Market Share by Country (2017-2022)
    Table 34. Europe Next Generation Cancer Diagnostics Market Size by Type (2017-2022) & ($ Millions)
    Table 35. Europe Next Generation Cancer Diagnostics Market Size Market Share by Type (2017-2022)
    Table 36. Europe Next Generation Cancer Diagnostics Market Size by Application (2017-2022) & ($ Millions)
    Table 37. Europe Next Generation Cancer Diagnostics Market Size Market Share by Application (2017-2022)
    Table 38. Middle East & Africa Next Generation Cancer Diagnostics Market Size by Region (2017-2022) & ($ Millions)
    Table 39. Middle East & Africa Next Generation Cancer Diagnostics Market Size Market Share by Region (2017-2022)
    Table 40. Middle East & Africa Next Generation Cancer Diagnostics Market Size by Type (2017-2022) & ($ Millions)
    Table 41. Middle East & Africa Next Generation Cancer Diagnostics Market Size Market Share by Type (2017-2022)
    Table 42. Middle East & Africa Next Generation Cancer Diagnostics Market Size by Application (2017-2022) & ($ Millions)
    Table 43. Middle East & Africa Next Generation Cancer Diagnostics Market Size Market Share by Application (2017-2022)
    Table 44. Key Market Drivers & Growth Opportunities of Next Generation Cancer Diagnostics
    Table 45. Key Market Challenges & Risks of Next Generation Cancer Diagnostics
    Table 46. Key Industry Trends of Next Generation Cancer Diagnostics
    Table 47. Global Next Generation Cancer Diagnostics Market Size Forecast by Regions (2023-2028) & ($ Millions)
    Table 48. Global Next Generation Cancer Diagnostics Market Size Market Share Forecast by Regions (2023-2028)
    Table 49. Global Next Generation Cancer Diagnostics Market Size Forecast by Type (2023-2028) & ($ Millions)
    Table 50. Global Next Generation Cancer Diagnostics Market Size Market Share Forecast by Type (2023-2028)
    Table 51. Global Next Generation Cancer Diagnostics Market Size Forecast by Application (2023-2028) & ($ Millions)
    Table 52. Global Next Generation Cancer Diagnostics Market Size Market Share Forecast by Application (2023-2028)
    Table 53. Cepheid Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors
    Table 54. Cepheid Next Generation Cancer Diagnostics Product Offered
    Table 55. Cepheid Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 56. Cepheid Main Business
    Table 57. Cepheid Latest Developments
    Table 58. Koninklijke Philips N.V Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors
    Table 59. Koninklijke Philips N.V Next Generation Cancer Diagnostics Product Offered
    Table 60. Koninklijke Philips N.V Main Business
    Table 61. Koninklijke Philips N.V Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 62. Koninklijke Philips N.V Latest Developments
    Table 63. F. Hoffmann-La Roche Ltd Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors
    Table 64. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Product Offered
    Table 65. F. Hoffmann-La Roche Ltd Main Business
    Table 66. F. Hoffmann-La Roche Ltd Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 67. F. Hoffmann-La Roche Ltd Latest Developments
    Table 68. Qiagen Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors
    Table 69. Qiagen Next Generation Cancer Diagnostics Product Offered
    Table 70. Qiagen Main Business
    Table 71. Qiagen Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 72. Qiagen Latest Developments
    Table 73. Novartis AG Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors
    Table 74. Novartis AG Next Generation Cancer Diagnostics Product Offered
    Table 75. Novartis AG Main Business
    Table 76. Novartis AG Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 77. Novartis AG Latest Developments
    Table 78. Abbott Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors
    Table 79. Abbott Next Generation Cancer Diagnostics Product Offered
    Table 80. Abbott Main Business
    Table 81. Abbott Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 82. Abbott Latest Developments
    Table 83. Thermo Fisher Scientific Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors
    Table 84. Thermo Fisher Scientific Next Generation Cancer Diagnostics Product Offered
    Table 85. Thermo Fisher Scientific Main Business
    Table 86. Thermo Fisher Scientific Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 87. Thermo Fisher Scientific Latest Developments
    Table 88. Opko Health Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors
    Table 89. Opko Health Next Generation Cancer Diagnostics Product Offered
    Table 90. Opko Health Main Business
    Table 91. Opko Health Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 92. Opko Health Latest Developments
    Table 93. Myriad Genetics Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors
    Table 94. Myriad Genetics Next Generation Cancer Diagnostics Product Offered
    Table 95. Myriad Genetics Main Business
    Table 96. Myriad Genetics Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 97. Myriad Genetics Latest Developments
    Table 98. Agilent Technologies Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors
    Table 99. Agilent Technologies Next Generation Cancer Diagnostics Product Offered
    Table 100. Agilent Technologies Main Business
    Table 101. Agilent Technologies Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 102. Agilent Technologies Latest Developments
    Table 103. GE Healthcare Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors
    Table 104. GE Healthcare Next Generation Cancer Diagnostics Product Offered
    Table 105. GE Healthcare Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 106. GE Healthcare Main Business
    Table 107. GE Healthcare Latest Developments
    Table 108. PerkinElmer Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors
    Table 109. PerkinElmer Next Generation Cancer Diagnostics Product Offered
    Table 110. PerkinElmer Main Business
    Table 111. PerkinElmer Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 112. PerkinElmer Latest Developments
    Table 113. Genomic Health Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors
    Table 114. Genomic Health Next Generation Cancer Diagnostics Product Offered
    Table 115. Genomic Health Main Business
    Table 116. Genomic Health Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 117. Genomic Health Latest Developments
    Table 118. Illumina Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors
    Table 119. Illumina Next Generation Cancer Diagnostics Product Offered
    Table 120. Illumina Main Business
    Table 121. Illumina Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 122. Illumina Latest Developments
    Table 123. Hologic Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors
    Table 124. Hologic Next Generation Cancer Diagnostics Product Offered
    Table 125. Hologic Main Business
    Table 126. Hologic Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 127. Hologic Latest Developments
    Table 128. Almac Group Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors
    Table 129. Almac Group Next Generation Cancer Diagnostics Product Offered
    Table 130. Almac Group Main Business
    Table 131. Almac Group Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 132. Almac Group Latest Developments
    Table 133. Janssen Global Services Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors
    Table 134. Janssen Global Services Next Generation Cancer Diagnostics Product Offered
    Table 135. Janssen Global Services Main Business
    Table 136. Janssen Global Services Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 137. Janssen Global Services Latest Developments
    Table 138. Sysmex Corporation Details, Company Type, Next Generation Cancer Diagnostics Area Served and Its Competitors
    Table 139. Sysmex Corporation Next Generation Cancer Diagnostics Product Offered
    Table 140. Sysmex Corporation Main Business
    Table 141. Sysmex Corporation Next Generation Cancer Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 142. Sysmex Corporation Latest Developments
List of Figures
    Figure 1. Next Generation Cancer Diagnostics Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Next Generation Cancer Diagnostics Market Size Growth Rate 2017-2028 ($ Millions)
    Figure 6. Global Next Generation Cancer Diagnostics Market Size Market Share by Type in 2021
    Figure 7. Next Generation Cancer Diagnostics in Hospitals
    Figure 8. Global Next Generation Cancer Diagnostics Market: Hospitals (2017-2022) & ($ Millions)
    Figure 9. Next Generation Cancer Diagnostics in Clinics
    Figure 10. Global Next Generation Cancer Diagnostics Market: Clinics (2017-2022) & ($ Millions)
    Figure 11. Next Generation Cancer Diagnostics in Others
    Figure 12. Global Next Generation Cancer Diagnostics Market: Others (2017-2022) & ($ Millions)
    Figure 13. Global Next Generation Cancer Diagnostics Market Size Market Share by Application in 2021
    Figure 14. Global Next Generation Cancer Diagnostics Revenue Market Share by Player in 2021
    Figure 15. Global Next Generation Cancer Diagnostics Market Size Market Share by Regions (2017-2022)
    Figure 16. Americas Next Generation Cancer Diagnostics Market Size 2017-2022 ($ Millions)
    Figure 17. APAC Next Generation Cancer Diagnostics Market Size 2017-2022 ($ Millions)
    Figure 18. Europe Next Generation Cancer Diagnostics Market Size 2017-2022 ($ Millions)
    Figure 19. Middle East & Africa Next Generation Cancer Diagnostics Market Size 2017-2022 ($ Millions)
    Figure 20. Americas Next Generation Cancer Diagnostics Value Market Share by Country in 2021
    Figure 21. Americas Next Generation Cancer Diagnostics Consumption Market Share by Type in 2021
    Figure 22. Americas Next Generation Cancer Diagnostics Market Size Market Share by Application in 2021
    Figure 23. United States Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 24. Canada Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 25. Mexico Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 26. Brazil Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 27. APAC Next Generation Cancer Diagnostics Market Size Market Share by Region in 2021
    Figure 28. APAC Next Generation Cancer Diagnostics Market Size Market Share by Application in 2021
    Figure 29. China Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 30. Japan Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 31. Korea Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 32. Southeast Asia Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 33. India Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 34. Australia Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 35. Europe Next Generation Cancer Diagnostics Market Size Market Share by Country in 2021
    Figure 36. Europe Next Generation Cancer Diagnostics Market Size Market Share by Type in 2021
    Figure 37. Europe Next Generation Cancer Diagnostics Market Size Market Share by Application in 2021
    Figure 38. Germany Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 39. France Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 40. UK Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 41. Italy Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 42. Russia Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 43. Middle East & Africa Next Generation Cancer Diagnostics Market Size Market Share by Region in 2021
    Figure 44. Middle East & Africa Next Generation Cancer Diagnostics Market Size Market Share by Type in 2021
    Figure 45. Middle East & Africa Next Generation Cancer Diagnostics Market Size Market Share by Application in 2021
    Figure 46. Egypt Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 47. South Africa Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 48. Israel Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 49. Turkey Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 50. GCC Country Next Generation Cancer Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 51. Americas Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 52. APAC Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 53. Europe Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 54. Middle East & Africa Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 55. United States Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 56. Canada Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 57. Mexico Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 58. Brazil Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 59. China Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 60. Japan Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 61. Korea Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 62. Southeast Asia Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 63. India Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 64. Australia Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 65. Germany Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 66. France Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 67. UK Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 68. Italy Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 69. Russia Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 70. Spain Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 71. Egypt Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 72. South Africa Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 73. Israel Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 74. Turkey Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 75. GCC Countries Next Generation Cancer Diagnostics Market Size 2023-2028 ($ Millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Next Generation Cancer Diagnostics Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Next Generation Cancer Diagnostics Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Next Generation Cancer Diagnostics Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports